Study: Some pharmas are slackers in reporting serious events
This article was originally published in Scrip
Executive Summary
Drug makers miss the FDA's 15-day deadline 10% of the time for reporting deaths, life-threatening side effects and other serious or unexpected adverse events (AEs) related to the firms' medicines, researchers said on 27 July in an article published in the Journal of the American Medical Association (JAMA) Internal Medicine.